drugset / Trial / NCT00435409
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
RandomizedCrossoverOpen-labelTreatment
Summary
The treatment received with sunitinib plus capecitabine could delay tumor growth longer than with treatment with capecitabine alone.
Timeline
- Start
- 2007-02
- Primary completion
- 2009-12
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | 2000 mg/m2 | Oral |
| Comparator | Capecitabine | Small molecule | 2500 mg/m2 | Oral |
| Subject | Sunitinib | Small molecule | 37.5 mg | Oral |